Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study

Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterologie a hepatologie 2016-02, Vol.70 (1), p.27-36
Hauptverfasser: Hlavatý, Tibor, Krajčovičová, Anna, Šturdík, Igor, Letkovský, Juraj, Koller, Tomáš, Tóth, Jozef, Huorka, Martin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 36
container_issue 1
container_start_page 27
container_title Gastroenterologie a hepatologie
container_volume 70
creator Hlavatý, Tibor
Krajčovičová, Anna
Šturdík, Igor
Letkovský, Juraj
Koller, Tomáš
Tóth, Jozef
Huorka, Martin
description
doi_str_mv 10.14735/amgh201627
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_14735_amgh201627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_14735_amgh201627</sourcerecordid><originalsourceid>FETCH-LOGICAL-c787-e7b7852cc7d36dec4d13728b68a65c36d3fa725ab19c560b216cc15a220c7edc3</originalsourceid><addsrcrecordid>eNpFULtOAzEQtBBIRCEVP-AeDH7c2UcJES8pEhQp6E57vr3E6B6RbQjX0fAF_CFfghUiUe1oZnY1O4ScCn4hMqPyS-hWa8mFluaATETBM1Zw9XK4x6Yw2TGZhfDKOZeJUppPyNeNG4LrXAueur5p3YfroKLzJXsWikaPEDvsY9LoBqJLMNCti-udGboO4uBHWg1bbGntAkLAQH8-vynQoUc2IvhzGly_apHZtO2Reox-CBu00b0jDfGtHk_IUQNtwNl-Tsny7nY5f2CLp_vH-fWC2ZSeoalMkUtrTa10jTarhTKyqHQBOreJUg0YmUMlrmyueSWFtlbkICW3BmurpuTs76xNAYLHptz49K4fS8HLXYflf4fqF0yGaIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hlavatý, Tibor ; Krajčovičová, Anna ; Šturdík, Igor ; Letkovský, Juraj ; Koller, Tomáš ; Tóth, Jozef ; Huorka, Martin</creator><creatorcontrib>Hlavatý, Tibor ; Krajčovičová, Anna ; Šturdík, Igor ; Letkovský, Juraj ; Koller, Tomáš ; Tóth, Jozef ; Huorka, Martin</creatorcontrib><identifier>ISSN: 1804-7874</identifier><identifier>EISSN: 1804-803X</identifier><identifier>DOI: 10.14735/amgh201627</identifier><language>eng</language><ispartof>Gastroenterologie a hepatologie, 2016-02, Vol.70 (1), p.27-36</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c787-e7b7852cc7d36dec4d13728b68a65c36d3fa725ab19c560b216cc15a220c7edc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Hlavatý, Tibor</creatorcontrib><creatorcontrib>Krajčovičová, Anna</creatorcontrib><creatorcontrib>Šturdík, Igor</creatorcontrib><creatorcontrib>Letkovský, Juraj</creatorcontrib><creatorcontrib>Koller, Tomáš</creatorcontrib><creatorcontrib>Tóth, Jozef</creatorcontrib><creatorcontrib>Huorka, Martin</creatorcontrib><title>Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study</title><title>Gastroenterologie a hepatologie</title><issn>1804-7874</issn><issn>1804-803X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpFULtOAzEQtBBIRCEVP-AeDH7c2UcJES8pEhQp6E57vr3E6B6RbQjX0fAF_CFfghUiUe1oZnY1O4ScCn4hMqPyS-hWa8mFluaATETBM1Zw9XK4x6Yw2TGZhfDKOZeJUppPyNeNG4LrXAueur5p3YfroKLzJXsWikaPEDvsY9LoBqJLMNCti-udGboO4uBHWg1bbGntAkLAQH8-vynQoUc2IvhzGly_apHZtO2Reox-CBu00b0jDfGtHk_IUQNtwNl-Tsny7nY5f2CLp_vH-fWC2ZSeoalMkUtrTa10jTarhTKyqHQBOreJUg0YmUMlrmyueSWFtlbkICW3BmurpuTs76xNAYLHptz49K4fS8HLXYflf4fqF0yGaIQ</recordid><startdate>20160229</startdate><enddate>20160229</enddate><creator>Hlavatý, Tibor</creator><creator>Krajčovičová, Anna</creator><creator>Šturdík, Igor</creator><creator>Letkovský, Juraj</creator><creator>Koller, Tomáš</creator><creator>Tóth, Jozef</creator><creator>Huorka, Martin</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20160229</creationdate><title>Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study</title><author>Hlavatý, Tibor ; Krajčovičová, Anna ; Šturdík, Igor ; Letkovský, Juraj ; Koller, Tomáš ; Tóth, Jozef ; Huorka, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c787-e7b7852cc7d36dec4d13728b68a65c36d3fa725ab19c560b216cc15a220c7edc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hlavatý, Tibor</creatorcontrib><creatorcontrib>Krajčovičová, Anna</creatorcontrib><creatorcontrib>Šturdík, Igor</creatorcontrib><creatorcontrib>Letkovský, Juraj</creatorcontrib><creatorcontrib>Koller, Tomáš</creatorcontrib><creatorcontrib>Tóth, Jozef</creatorcontrib><creatorcontrib>Huorka, Martin</creatorcontrib><collection>CrossRef</collection><jtitle>Gastroenterologie a hepatologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hlavatý, Tibor</au><au>Krajčovičová, Anna</au><au>Šturdík, Igor</au><au>Letkovský, Juraj</au><au>Koller, Tomáš</au><au>Tóth, Jozef</au><au>Huorka, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study</atitle><jtitle>Gastroenterologie a hepatologie</jtitle><date>2016-02-29</date><risdate>2016</risdate><volume>70</volume><issue>1</issue><spage>27</spage><epage>36</epage><pages>27-36</pages><issn>1804-7874</issn><eissn>1804-803X</eissn><doi>10.14735/amgh201627</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1804-7874
ispartof Gastroenterologie a hepatologie, 2016-02, Vol.70 (1), p.27-36
issn 1804-7874
1804-803X
language eng
recordid cdi_crossref_primary_10_14735_amgh201627
source EZB-FREE-00999 freely available EZB journals
title Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A38%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biosimilar%20infliximab%20CT-P13%20treatment%20in%20patients%20with%20inflammatory%20bowel%20diseases%20%E2%80%93%20a%20one-year,%20single-centre%20retrospective%20study&rft.jtitle=Gastroenterologie%20a%20hepatologie&rft.au=Hlavat%C3%BD,%20Tibor&rft.date=2016-02-29&rft.volume=70&rft.issue=1&rft.spage=27&rft.epage=36&rft.pages=27-36&rft.issn=1804-7874&rft.eissn=1804-803X&rft_id=info:doi/10.14735/amgh201627&rft_dat=%3Ccrossref%3E10_14735_amgh201627%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true